Introduction
The medical condition called stroke happens mainly due to clot or embolus formation in the blood vessels that supply blood to different parts of brain. Hence, the doctors combine standard medication and surgical removal of clot to restore the blood flow at the affected site. This approach may in the end provide long-term positive outcomes. A study by a group of researchers has found the efficacy of this method. The authors of the study have published the details of this method in New England Journal of Medicine. In this article, we will walk the readers through the new game-changing approach developed by the research team.
Game-changing Approach
The study has provided a radically new approach for treating certain types of strokes. Dr Demetrius Lopes who is the surgical director of comprehensive stroke centre at Rush University Medical Centre has echoed this view. He is also the co-author of the study. By means of this approach, the researchers have been able to drastically improve the lifestyle of people who had suffered stroke. Normally, people with strokes have been left to care for themselves as nobody knows anything about this medical condition. Mostly stroke patients need the help of other people to remain active. Hence, the relatives of affected patients need some training on this. The research group has christened this study as SWIFT PRIME - Solitaire With the Intention for Thrombectomy as PRIMary Endovascular - treatment. The need for the post-operative care by trained fellows is once again highlighted by this study.
Departure from Traditional Approach
The normal approach to treat ischemic stroke is intravenous tissue plasminogen activator. The physicians have to intervene with suitable treatment within first 3-4 hours of symptoms of the stroke. This treatment would dissolve the clot formed within the blood vessels of the brain. It would involve the insertion of a catheter through an incision in the patient's groin to reach the affected site in the brain. After reaching the site, the doctor uses a device attached to the catheter to grab and dislodge the clot. After this procedure, the surgeons take the device out through an incision made on the body. At present, intravenous tissue plasminogen activator is the only approved method available for the ischemic stroke treatment across the world. The clinical trials use Thrombectomy to do the same in animal models. The study has come out positively in animal models. Before trying on human beings, the new method has to undergo several rounds of thorough clinical trials to rule out unforeseen side effects.
The medical condition called stroke happens mainly due to clot or embolus formation in the blood vessels that supply blood to different parts of brain. Hence, the doctors combine standard medication and surgical removal of clot to restore the blood flow at the affected site. This approach may in the end provide long-term positive outcomes. A study by a group of researchers has found the efficacy of this method. The authors of the study have published the details of this method in New England Journal of Medicine. In this article, we will walk the readers through the new game-changing approach developed by the research team.
Game-changing Approach
The study has provided a radically new approach for treating certain types of strokes. Dr Demetrius Lopes who is the surgical director of comprehensive stroke centre at Rush University Medical Centre has echoed this view. He is also the co-author of the study. By means of this approach, the researchers have been able to drastically improve the lifestyle of people who had suffered stroke. Normally, people with strokes have been left to care for themselves as nobody knows anything about this medical condition. Mostly stroke patients need the help of other people to remain active. Hence, the relatives of affected patients need some training on this. The research group has christened this study as SWIFT PRIME - Solitaire With the Intention for Thrombectomy as PRIMary Endovascular - treatment. The need for the post-operative care by trained fellows is once again highlighted by this study.
Departure from Traditional Approach
The normal approach to treat ischemic stroke is intravenous tissue plasminogen activator. The physicians have to intervene with suitable treatment within first 3-4 hours of symptoms of the stroke. This treatment would dissolve the clot formed within the blood vessels of the brain. It would involve the insertion of a catheter through an incision in the patient's groin to reach the affected site in the brain. After reaching the site, the doctor uses a device attached to the catheter to grab and dislodge the clot. After this procedure, the surgeons take the device out through an incision made on the body. At present, intravenous tissue plasminogen activator is the only approved method available for the ischemic stroke treatment across the world. The clinical trials use Thrombectomy to do the same in animal models. The study has come out positively in animal models. Before trying on human beings, the new method has to undergo several rounds of thorough clinical trials to rule out unforeseen side effects.
A group of researchers has developed a new method to treat
ischemic stroke by combining the medicinal approach with surgical
intervention. It has a number of positive effects. This article goes at
some length on this new method for the benefit of readers. For more such
information, the readers can visit the link http://tvmbala.blogspot.com.
0 Response to " A New Game-Changing Method Was Developed to Treat Strokes"
Post a Comment